Literature DB >> 2642091

The polymorphonuclear leucocyte count in childhood haemolytic uraemic syndrome.

M D Walters1, I U Matthei, R Kay, M J Dillon, T M Barratt.   

Abstract

Review of data from 79 children with the haemolytic uraemic syndrome (HUS) showed that the polymorphonuclear leucocyte (PMN) count at presentation in childhood HUS predicts outcome. Logistic regression analysis of several features at presentation identified only the PMN count and the presence of a diarrhoeal prodrome as having a significant effect on the outcome (P less than 0.01 and P less than 0.001 respectively). The geometric mean PMN count was significantly raised in 70 children who had typical HUS following a diarrhoeal prodrome (D+ cases) compared with that of 9 children who had atypical disease without diarrhoea (D- cases) (t-test on log-transformed data, P less than 0.005). Fifty-seven children with D+ HUS who recovered completely had a significantly lower geometric mean PMN count than D+ cases with a bad outcome (P less than 0.001). Four of these patients, who died in the acute stage of the disease, had a significantly higher mean count than the rest of the D+ patients (P less than 0.001). Multiple regression analysis demonstrated that the PMN count in D+ cases was not significantly influenced by haemoglobin concentration, platelet count, length of the prodrome, or the administration of antibiotics in the prodromal period. A high PMN count at presentation in D+ HUS indicates a poor prognosis. The data emphasise the heterogeneity of HUS and suggest that PMN participate in the pathogenesis of the disorder in typical D+ cases but not in atypical D- cases.

Entities:  

Mesh:

Year:  1989        PMID: 2642091     DOI: 10.1007/bf00852893

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  21 in total

1.  Oxygen radicals mediate endothelial cell damage by complement-stimulated granulocytes. An in vitro model of immune vascular damage.

Authors:  T Sacks; C F Moldow; P R Craddock; T K Bowers; H S Jacob
Journal:  J Clin Invest       Date:  1978-05       Impact factor: 14.808

2.  Yersinia pseudotuberculosis septicemia.

Authors:  C G Prober; B Tune; L Hoder
Journal:  Am J Dis Child       Date:  1979-06

3.  Haemolytic uraemic syndrome.

Authors:  M Levin; J M Barratt
Journal:  Arch Dis Child       Date:  1984-05       Impact factor: 3.791

4.  Hemolytic uremic syndrome in families.

Authors:  B S Kaplan; R W Chesney; K N Drummond
Journal:  N Engl J Med       Date:  1975-05-22       Impact factor: 91.245

5.  Low red cell arachidonic acid in hemolytic uremic syndrome.

Authors:  H R Powell; V Groves; D A McCredie; A Yong; J Pitt
Journal:  Clin Nephrol       Date:  1987-01       Impact factor: 0.975

6.  Human vascular smooth muscle cells and endothelial cells lack catalase activity and are susceptible to hydrogen peroxide.

Authors:  M Shingu; K Yoshioka; M Nobunaga; K Yoshida
Journal:  Inflammation       Date:  1985-09       Impact factor: 4.092

7.  Campylobacter jejuni-associated hemolytic-uremic syndrome in a mother and daughter.

Authors:  B N Chamovitz; A I Hartstein; S R Alexander; A B Terry; P Short; R Katon
Journal:  Pediatrics       Date:  1983-02       Impact factor: 7.124

8.  Neutrophil-mediated injury to endothelial cells. Enhancement by endotoxin and essential role of neutrophil elastase.

Authors:  L A Smedly; M G Tonnesen; R A Sandhaus; C Haslett; L A Guthrie; R B Johnston; P M Henson; G S Worthen
Journal:  J Clin Invest       Date:  1986-04       Impact factor: 14.808

9.  Haemolytic-uraemic syndrome: an analysis of prognostic features.

Authors:  R S Trompeter; R Schwartz; C Chantler; M J Dillon; G B Haycock; R Kay; T M Barratt
Journal:  Arch Dis Child       Date:  1983-02       Impact factor: 3.791

10.  Laboratory investigation of hemorrhagic colitis outbreaks associated with a rare Escherichia coli serotype.

Authors:  J G Wells; B R Davis; I K Wachsmuth; L W Riley; R S Remis; R Sokolow; G K Morris
Journal:  J Clin Microbiol       Date:  1983-09       Impact factor: 5.948

View more
  43 in total

1.  Shiga toxin 2 induces macrophage-granulocyte colonies from human bone marrow and cord blood stem cells.

Authors:  Shin Chiyoda; Tae Takeda; Yosuke Aoki
Journal:  Infect Immun       Date:  2002-09       Impact factor: 3.441

Review 2.  New insights into the haemolytic uraemic syndromes.

Authors:  D V Milford; C M Taylor
Journal:  Arch Dis Child       Date:  1990-07       Impact factor: 3.791

3.  Shiga toxin 2 and flagellin from shiga-toxigenic Escherichia coli superinduce interleukin-8 through synergistic effects on host stress-activated protein kinase activation.

Authors:  Dakshina M Jandhyala; Trisha J Rogers; Anne Kane; Adrienne W Paton; James C Paton; Cheleste M Thorpe
Journal:  Infect Immun       Date:  2010-05-03       Impact factor: 3.441

4.  A plea for standardized terminology within the haemolytic uraemic syndromes.

Authors:  C M Taylor; D V Milford; R H White
Journal:  Pediatr Nephrol       Date:  1991-01       Impact factor: 3.714

5.  Molecular damage and induction of proinflammatory cytokines in human endothelial cells exposed to Shiga toxin 1, Shiga toxin 2, and alpha-sarcin.

Authors:  Maurizio Brigotti; Domenica Carnicelli; Elisa Ravanelli; Antonio González Vara; Chiara Martinelli; Roberta R Alfieri; Pier Giorgio Petronini; Piero Sestili
Journal:  Infect Immun       Date:  2007-02-12       Impact factor: 3.441

6.  CXCL1/KC and CXCL2/MIP-2 are critical effectors and potential targets for therapy of Escherichia coli O157:H7-associated renal inflammation.

Authors:  James K Roche; Tiffany R Keepers; Lisa K Gross; Regina M Seaner; Tom G Obrig
Journal:  Am J Pathol       Date:  2007-02       Impact factor: 4.307

Review 7.  Current views on aetiology and management of haemolytic uraemic syndrome.

Authors:  M M Fitzpatrick; M J Dillon
Journal:  Postgrad Med J       Date:  1991-08       Impact factor: 2.401

Review 8.  Advances in haemolytic uraemic syndrome.

Authors:  C M Taylor; L A Monnens
Journal:  Arch Dis Child       Date:  1998-02       Impact factor: 3.791

9.  Impact of platelet transfusions in children with post-diarrheal hemolytic uremic syndrome.

Authors:  Alejandro Balestracci; Sandra Mariel Martin; Ismael Toledo; Caupolican Alvarado; Raquel Eva Wainsztein
Journal:  Pediatr Nephrol       Date:  2013-02-06       Impact factor: 3.714

10.  Risk factors for poor renal prognosis in children with hemolytic uremic syndrome.

Authors:  Alessandra Gianviti; Alberto E Tozzi; Laura De Petris; Alfredo Caprioli; Lucilla Ravà; Alberto Edefonti; Gianluigi Ardissino; Giovanni Montini; Graziella Zacchello; Alfonso Ferretti; Carmine Pecoraro; Tommaso De Palo; Angela Caringella; Maurizio Gaido; Rosanna Coppo; Francesco Perfumo; Nunzia Miglietti; Ilse Ratsche; Rosa Penza; Giovambattista Capasso; Silvio Maringhini; Salvatore Li Volti; Carmen Setzu; Marco Pennesi; Alberto Bettinelli; Leopoldo Peratoner; Ivana Pela; Elio Salvaggio; Giuliana Lama; Salvatore Maffei; Gianfranco Rizzoni
Journal:  Pediatr Nephrol       Date:  2003-10-31       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.